Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 15Pancreatic Fistula 4Recurrence 1Pancreatitis, Chronic 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Hemorrhage 1Fatty Liver 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1Bile Duct Neoplasms 1

Interventions

Surgical Procedures, Operative 7Liver Transplantation 5Lenalidomide 4Blood Specimen Collection 4pomalidomide 3Neoadjuvant Therapy 3Liquid Biopsy 3gilteritinib 2Therapeutics 2Rituximab 2Proteasome Inhibitors 2Observation 2Mohs Surgery 2Mitomycin 2Magnetic Resonance Spectroscopy 2Immunotherapy, Adoptive 2Immunoconjugates 2High-Throughput Nucleotide Sequencing 2Fluorouracil 2Drug Therapy 2DNA, Mitochondrial 2Brentuximab Vedotin 2Bendamustine Hydrochloride 2Antibodies, Monoclonal 2Antibodies, Bispecific 2Amplified Fragment Length Polymorphism Analysis 2trametinib 1romidepsin 1nedaplatin 1lenvatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Recurrence × Pancreaticoduodenectomy × Clear all
NCT04596865 2023-11-18

Recurrence After Whipple's (RAW) Study

University Hospital Plymouth NHS Trust

Completed
1,484 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms, Recurrence, Cholangiocarcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡